An international trial has shown a new drug could improve breast cancer survival rates by up to 30 per cent.
Lead researcher Sara Hurvitz said the treatment is safer than traditional chemotherapy since it can target cancer cells more precisely.
The trial involved women under the age of 59 who were diagnosed with cancer at a later stage in the disease.